Alagille syndrome and nephroblastoma: Unusual coincidence of two rare disorders

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 908-911

  Bourdeaut, Franck ^a,b   Guiochon Mantel, Anne ^c   Fabre, Monique ^c   Martelli, Hélène ^c   Patte, Catherine ^d   Porta, Gilda ^e   Bernard, Olivier ^c   Delattre, Olivier ^b   Jacquemin, Emmanuel ^c  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1p; Alagille; JAG1; Nephroblastoma; NOTCH

Indexed keywords

ALAGILLE SYNDROME; ARTICLE; BILE DUCT MALFORMATION; CASE REPORT; CHILD; CHROMOSOME 1P; CHROMOSOME 20P; CHROMOSOME DELETION; CONGENITAL HEART MALFORMATION; EYE MALFORMATION; FACE DYSMORPHIA; FEMALE; GENE; GENE IDENTIFICATION; HUMAN; JAG1 GENE; KIDNEY MALFORMATION; MISSENSE MUTATION; NEPHROBLASTOMA; PRIORITY JOURNAL; RARE DISEASE; VERTEBRA MALFORMATION;

ALAGILLE SYNDROME; CALCIUM-BINDING PROTEINS; CHILD, PRESCHOOL; FEMALE; GENE DELETION; HUMANS; INFANT; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MEMBRANE PROTEINS; MUTATION; NUCLEIC ACID HYBRIDIZATION; WILMS TUMOR;

EID: 40449125212     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21255     Document Type: Article

References (16)

1. Nishi M, Miyake H, Takeda T, et al. Congenital malformations and childhood cancer. Med Ped Oncol 2000;34:250-254.
2. Stiller CA, Lennox EL, Wilson LM. Incidence of cardiac septal defects in children with Wilms' tumour and other malignant diseases. Carcinogenesis 1987;8:129-132.
3. Lykavieris P, Hadchouel M, Chardot C, et al. Outcome of liver disease in children with Alagille syndrome: A study of 163 patients. Gut 2001;49:431-435.
4. Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: Frequency and relation to prognosis. Hepatology 1999;29:822-829.
5. Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged 1, which encodes a ligand for Notch 1. Nat Genet 1997;16:243-251.
6. Colliton RP, Bason L, Lu FM, et al. Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mut 2001;17:151-152.
7. Röpke A, Kujat A, Gräber M, et al. Identification of 36 novel Jagged1 (JAG1) mutations in patients with Alagille syndrome. Hum Mut 2003;21:100-104.
8. Kim B, Park SH, Yang HR, et al. Hepatocellular carcinoma occurring in Alagille syndrome. Pathol Res Pract 2005;201:55-60.
9. Habib R, Dommergues JP, Gubler C, et al. Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol 1987;1:455-464.
10. Harendza S, Hubner CA, Glaser C. Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation. J Nephrol 2005;18:312-317.
11. Graber C, von Boehmer H, Look AT. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Cancer Rev 2006;6:347-359.
12. Grego-Bessa J, Diez J, Timmerman L, et al. Notch and epithelial- mesenchyme transition in development and tumor progression: Another turn of the screw. Cell cycle 2004;3:718-721.
13. McDaniel R, Wharten DM, Sanchez-Lara PA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006;79:169-173.
14. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 2005;23:7312-7321.
15. Natrajan R, Williams RD, Hing SN, et al. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol 2006;210:49-58.
16. Altura RA, Valentine M, Li H, et al. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization. Cancer Res 1996;56:3837-3841.